Pharma & Biotech

Shares of Nektar Therapeutics surged to unprecedented heights this week, reaching a new 52-week peak of $61.24 before settling at...

Cellectar Biosciences is attracting significant market attention following the release of encouraging interim data from its CLOVER-2 Phase 1b study....

Ocugen is executing a strategic campaign to position itself at the forefront of gene therapy. The company has announced a...

DexCom, the continuous glucose monitoring specialist, finds itself navigating turbulent market conditions as conflicting signals emerge about the company's near-term...

Amphastar Pharmaceuticals finds itself at a puzzling crossroads as conflicting market signals create uncertainty for investors. While fundamental valuation metrics...

Viking Therapeutics shares delivered a contradictory performance on Tuesday, advancing 1.86 percent to reach $27.88 and outpacing the S&P 500's...

Bayer's stock faces a pivotal moment as Germany's DAX-listed pharmaceutical and agricultural giant tests the psychologically significant €30 price level....

Pharmaceutical giant Novo Nordisk is making calculated moves to sharpen its competitive edge, simultaneously advancing key pipeline assets while exiting...

Wednesday delivered an unexpected boost for Moderna as the biotechnology firm's stock surged more than 6%, marking a dramatic reversal...

Danaher Corporation is making significant strides in artificial intelligence integration across its life sciences portfolio, earning market approval for its...